Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1982 Nov 13;285(6352):1387–1392. doi: 10.1136/bmj.285.6352.1387

Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol

J S Floras, J V Jones, M O Hassan, P Sleight
PMCID: PMC1500409  PMID: 6814568

Abstract

Intra-arterial ambulatory blood pressure was measured over 24 hours, in 34 patients with newly diagnosed hypertension, both before and after double-blind randomisation to treatment with atenolol (n=9), metoprolol (n=9), pindolol (n=9), or propranolol in its slow-release form (n=7). The dosage of each drug was adjusted at monthly clinic visits until satisfactory control of blood pressure was achieved (140/90 mm Hg or less by cuff) or the maximum dose in the study protocol was reached. A second intra-arterial recording was made after these drugs had been taken once daily at 0800 for three to eight months (mean 5·0±SD 1·4) and was started four hours after the last dose.

At the end of the 24-hour recordings blood pressure was significantly lower with all four drugs. The extent to which the drugs reduced blood pressure, however, differed over the 24 hours. Atenolol lowered mean arterial pressure significantly throughout all 24 recorded hours, metoprolol for 12 hours, pindolol for 15 hours, and slow-release propranolol for 22 hours. Neither metoprolol nor pindolol lowered blood pressure during sleep. A significant reduction in heart rate was observed over 20 hours with atenolol, 20 hours with metoprolol, 10 hours with pindolol, and 24 hours with slow-release propranolol. Atenolol, metoprolol, and slow-release propranolol continued to slow the heart rate 24 hours after the last tablet was taken; this effect on heart rate, however, was not sustained throughout the second morning in those patients taking atenolol. Pindolol, the only drug studied that has intrinsic sympathomimetic activity, increased heart rate and did not lower blood pressure during sleep.

Atenolol and slow-release propranolol are effective as antihypertensive agents over 24 hours when taken once daily, whereas metoprolol and pindolol may need to be taken more frequently. At times of low sympathetic tone, however, such as during sleep, beta-blockers with intrinsic sympathomimetic activity may raise heart rate and attenuate the fall in blood pressure with treatment.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amery A., De Plaen J. F., Lijnen P., McAinsh J., Reybrouck T. Relationship between blood level of atenolol and pharmacologic effect. Clin Pharmacol Ther. 1977 Jun;21(6):691–699. doi: 10.1002/cpt1977216691. [DOI] [PubMed] [Google Scholar]
  2. Blackwell B. The drug defaulter. Clin Pharmacol Ther. 1972 Nov-Dec;13(6):841–848. doi: 10.1002/cpt1972135part2841. [DOI] [PubMed] [Google Scholar]
  3. Brundin T., Edhag O., Lundman T. Effects remaining after withdrawal of long-term beta-receptor blockade. Reduced heart rate and altered haemodynamic response to acute propranolol administration. Br Heart J. 1976 Oct;38(10):1065–1072. doi: 10.1136/hrt.38.10.1065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Castleden C. M., Dathan J. R., George C. F. A comparison of once and twice daily atenolol in hypertension. Postgrad Med J. 1977 Nov;53(625):679–682. doi: 10.1136/pgmj.53.625.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Douglas-Jones A. P., Baber N. S., Lee A. Once daily propranolol in the treatment of mild to moderate hypertension: a dose range finding study. Eur J Clin Pharmacol. 1978 Nov 27;14(3):163–166. doi: 10.1007/BF02089954. [DOI] [PubMed] [Google Scholar]
  6. Douglas-Jones A. P., Cruickshank J. M. Once-daily dosing with Atenolol in patients with mild or moderate hypertension. Br Med J. 1976 Apr 24;1(6016):990–991. doi: 10.1136/bmj.1.6016.990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Floras J. S., Jones J. V., Fox P., Hassan M. O., Turner K. L., Sleight P. Effects of long-term, once-daily administration of atenolol on ambulatory blood pressure of hypertensive patients. J Cardiovasc Pharmacol. 1981 Sep-Oct;3(5):958–964. doi: 10.1097/00005344-198109000-00005. [DOI] [PubMed] [Google Scholar]
  8. Frithz G. Pindolol once daily in the treatment of hypertension. Ups J Med Sci. 1976;81(3):151–154. doi: 10.3109/03009737609179040. [DOI] [PubMed] [Google Scholar]
  9. Gould B. A., Mann S., Davies A. B., Altman D. G., Raftery E. B. Does placebo lower blood-pressure? Lancet. 1981 Dec 19;2(8260-61):1377–1381. doi: 10.1016/s0140-6736(81)92799-9. [DOI] [PubMed] [Google Scholar]
  10. Gugler R., Bodem G. Single and multiple dose pharmacokinetics of pindolol. Eur J Clin Pharmacol. 1978 Mar 17;13(1):13–16. doi: 10.1007/BF00606675. [DOI] [PubMed] [Google Scholar]
  11. Harron D. W., Balnave K., Kinney C. D., Wilson R., Russell C. J., Shanks R. G. Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol. Clin Pharmacol Ther. 1981 Mar;29(3):295–302. doi: 10.1038/clpt.1981.39. [DOI] [PubMed] [Google Scholar]
  12. Jeffers T. A., Webster J., Petrie J. C., Barker N. P. Atenolol once-daily in hypertension. Br J Clin Pharmacol. 1977 Oct;4(5):523–527. doi: 10.1111/j.1365-2125.1977.tb00780.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Karlberg B. E., Nilsson O., Tolagen K., Nitelius E., Waern U. Once-daily metoprolol in primary hypertension. Clin Pharmacol Ther. 1979 Apr;25(4):399–407. doi: 10.1002/cpt1979254399. [DOI] [PubMed] [Google Scholar]
  14. Littler W. A., Honour A. J., Pugsley D. J., Sleight P. Continuous recording of direct arterial pressure in unrestricted patients. Its role in the diagnosis and management of high blood pressure. Circulation. 1975 Jun;51(6):1101–1106. doi: 10.1161/01.cir.51.6.1101. [DOI] [PubMed] [Google Scholar]
  15. Mann S., Craig M. W., Balasubramanian V., Cashman P. M., Raftery E. B. Ambulant blood pressure: reproducibility and the assessment of interventions. Clin Sci (Lond) 1980 Dec;59(6):497–500. doi: 10.1042/cs0590497. [DOI] [PubMed] [Google Scholar]
  16. Mann S., Craig M. W., Balasubramanian V., Raftery E. B. Propranolol LA and ambulatory blood pressure. Br J Clin Pharmacol. 1980 Nov;10(5):443–447. doi: 10.1111/j.1365-2125.1980.tb01786.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Marshall A. J., Barritt D. W., Harry J. D. Dose response and frequency of administration of atenolol in essential hypertension--once daily treatment with beta-blockade. Postgrad Med J. 1977;53 (Suppl 3):168–172. [PubMed] [Google Scholar]
  18. Petrie J. C., Jeffers T. A., Robb O. J., Scott A. K., Webster J. Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension. Br Med J. 1980 Jun 28;280(6231):1573–1574. doi: 10.1136/bmj.280.6231.1573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Reybrouck T., Amery A., Fagard R., Jousten P., Lijnen P., Meulepas E. Beta-blockers: once or three times a day? Br Med J. 1978 May 27;1(6124):1386–1388. doi: 10.1136/bmj.1.6124.1386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Shand D. G., Wood A. J. Propranolol withdrawal syndrome - why? Circulation. 1978 Aug;58(2):202–203. doi: 10.1161/01.cir.58.2.202. [DOI] [PubMed] [Google Scholar]
  21. Traub Y. M., Rosenfeld J. B. Once-a-day pindolol in hypertension. Clin Pharmacol Ther. 1977 May;21(5):588–592. doi: 10.1002/cpt1977215588. [DOI] [PubMed] [Google Scholar]
  22. Watson R. D., Stallard T. J., Littler W. A. Influence of once-daily administration of beta-adrenoceptor antagonists on arterial pressure and its variability. Lancet. 1979 Jun 9;1(8128):1210–1213. doi: 10.1016/s0140-6736(79)91896-8. [DOI] [PubMed] [Google Scholar]
  23. Wilcox R. G. Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension. Br Med J. 1978 Aug 5;2(6134):383–385. doi: 10.1136/bmj.2.6134.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Williams E. M., Hassan M. O., Floras J. S., Sleight P., Jones J. V. Adaptation of hypertensives to treatment with cardioselective and non-selective beta-blockers. Absence of correlation between bradycardia and blood pressure control, and reduction in slope of the QT/RR relation. Br Heart J. 1980 Nov;44(5):473–487. doi: 10.1136/hrt.44.5.473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Wilson M., Morgan G., Morgan T. The effect on blood pressure of beta-adrenoceptor blocking drugs administered once daily and their duration of action when therapy is ceased. Br J Clin Pharmacol. 1976 Oct;3(5):857–861. doi: 10.1111/j.1365-2125.1976.tb00638.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Wright J. M., McLeod P. J., McCullough W. Antihypertensive efficacy of a single bedtime dose of methyldopa. Clin Pharmacol Ther. 1976 Dec;20(6):733–737. doi: 10.1002/cpt1976206733. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES